A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer

BACKGROUND: The high mortality of patients with non-small cell lung cancer (NSCLC) emphasizes the necessity of identifying a robust and reliable prognostic signature for NSCLC patients. This study aimed to identify and validate a prognostic signature for the prediction of both disease-free survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Shuguang, Wei, Min, Zhang, Hailin, Chen, Anxian, Wu, Junhua, Wei, Jiwu, Dong, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515678/
https://www.ncbi.nlm.nih.gov/pubmed/31088477
http://dx.doi.org/10.1186/s12967-019-1899-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515678/
https://www.ncbi.nlm.nih.gov/pubmed/31088477
http://dx.doi.org/10.1186/s12967-019-1899-y

Ejemplares similares